Marble Bone Disease, clinically known as osteopetrosis, is a rare genetic disorder characterized by increased bone density and abnormal bone structure. This condition hinders proper bone remodeling, leading to bones becoming dense and brittle, resembling marble. Osteopetrosis results from mutations affecting the function of osteoclasts, the cells responsible for breaking down and reshaping bone tissue. Individuals with marble bone disease may experience skeletal abnormalities, such as fractures, deformities, and stunted growth. Additionally, the increased bone mass can interfere with bone marrow function, causing anemia and other hematological issues. Cranial nerve compression may occur, impacting vision, hearing, and facial nerve function. Treatment approaches for marble bone disease focus on managing symptoms and complications. Bone marrow transplantation may be considered in severe cases. Ongoing research aims to understand the genetic basis of osteopetrosis and develop targeted therapies to address the underlying causes of this rare and challenging condition.
Title : The etiological diagnosis of torticollis
Ali Al Kaissi, National Ilizarov Medical Research Center for Traumatology and Orthopaedics, Russian Federation, Austria
Title : Selective denervation for persistent knee pain after total knee arthroplasty: Long-term outcomes
Shaomin Shi, Medical College of Wisconsin, United States
Title : AI-Driven infrared imaging and telerobotics in orthopedics: Enhancing diagnostics, surgical precision, and postoperative care
Marcos Brioschi, American Academy of Thermology, United States
Title : A clinical audit assessing patients presenting with a supracondylar fracture
Muhammad Muneeb Safdar, Musgrove Park Hospital, United Kingdom
Title : Epidemiology of shoulder dislocations in the united states from 1990 to 2019: A temporal study using the global burden of disease database
Ambrose Loc Thanh Ngo, Kansas City University, United States
Title : A data driven approach to prehabilitation and rehabilitation for hip and knee replacement patients
Diana Hodgins, Dynamic Metrics Ltd, United Kingdom